GlassScriptPhysician profile
Kalpesh C Patel
NPI 1831396803
$11,341.65
in general payments reported to CMS, 2019-2025
52 companies · $1,463 in 2025
The $1,463 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,802 · 2020: $1,501 · 2021: $1,822 · 2022: $1,781 · 2023: $1,547 · 2024: $1,425 · 2025: $1,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,961 · Consulting Fee: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,960.50 |
| Consulting Fee | $475.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,304.68 | 2019-2025 | |
| Biogen, INC. | $1,139.67 | 2019-2025 | Tysabri, Vumerity, Avonex |
| Supernus Pharmaceuticals, INC. | $1,017.01 | 2019-2022 | |
| Lilly USA, LLC | $738.00 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Neurocrine Biosciences, INC. | $722.10 | 2019-2025 | Ingrezza, Ongentys |
| Alexion Pharmaceuticals, INC. | $616.38 | 2019-2025 | Ultomiris |
| Emd Serono, INC. | $535.32 | 2019-2024 | Mavenclad |
| Eisai INC. | $531.10 | 2019-2024 | |
| Sk Life Science, INC. | $463.28 | 2020-2025 | |
| Genzyme Corporation | $403.65 | 2019-2023 | |
| Abbvie INC. | $365.80 | 2019-2025 | |
| Ucb, INC. | $305.48 | 2019-2025 | Rystiggo, Zilbrysq |
| Sunovion Pharmaceuticals INC. | $275.47 | 2019-2022 | |
| Genentech USA, INC. | $255.00 | 2019-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Amgen INC. | $253.86 | 2019-2025 | Uplizna |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kalpesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.